K Pharma,Inc.

TSE:4896 Stock Report

Market Cap: JP¥8.5b

K PharmaInc Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Hiroaki Fukushima

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure8yrs
CEO ownership21.0%
Management average tenureno data
Board average tenure5.1yrs

Recent management updates

Recent updates

CEO

Hiroaki Fukushima (64 yo)

8yrs

Tenure

Hiroaki Fukushima is President & Representative Director of K Pharma,Inc. from November 2016. Hiroaki Fukushima Joined Eisai Co., Ltd.in 1988 and Seconded to Eisai Research Institute of Boston, Inc. in 20...

Board Members

NamePositionTenureCompensationOwnership
Hiroaki Fukushima
President & Representative Director8yrsno data20.99%
¥ 1.8b
Masato Matsumoto
CFO, MD & Director3.1yrsno datano data
Masaya Nakamura
CTO & Director5.1yrsno data11.05%
¥ 935.9m
Hideyuki Okano
CSO & Director5.1yrsno data11.05%
¥ 935.9m
Kentaro Yoshimatsu
Scientific Advisor6.8yrsno datano data
Keiko Hatta
Independent Outside Director2yrsno datano data
Akiko Isohata
Outside Auditor2.5yrsno datano data
Yasutaka Nishida
Outside Auditor5.1yrsno datano data
Shunsuke Toyokawa
Full-time Outside Auditor2.7yrsno datano data
Jun Nakanishi
Scientific Advisor4.8yrsno datano data
Masato Yano
Scientific Advisor5.8yrsno datano data

5.1yrs

Average Tenure

63.5yo

Average Age

Experienced Board: 4896's board of directors are considered experienced (5.1 years average tenure).